KCa3.1 is involved in the proliferation and migration of T cells, B cells, mast cells, macrophages, fibroblasts and dedifferentiated vascular smooth muscle cells and has, therefore, been widely considered as a potential target for use in some pathological conditions such as asthma, immunosuppression and in fibroproliferative disorders. Here, KCNN4 is linked to asthma.